Abbott Laboratories is “well positioned” to handle tariffs, CEO and Chairman Robert Ford said during a call with investors ...

The Abbott Park, Illinois-based company said it had profit of 76 cents per share. Earnings, adjusted for amortization costs and pretax expenses, came to $1.09 per share. The results topped Wall Street ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $144.82, a high estimate of $160.00, and a low estimate of $135.00. This upward trend is apparent, with the ...

(AP) — Abbott Laboratories (ABT ... The maker of infant formula, medical devices and drugs posted revenue of $10.36 billion in the period, which did not meet Street forecasts.

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4% year on year to $10.36 billion. Its non-GAAP profit of ...

Vijay Kumar; Analyst; Evercore Inc. Good morning and thank you for standing by. Welcome to Abbott's first-quarter 2025 earnings conference call. (Operator Instructions) This call is being recorded ...

Abbott Laboratories will make new investments in US manufacturing, with the impact of tariffs on medical devices and diagnostics looming over the industry. It expects to spend $500 million on two ...

(AP) — Abbott Laboratories (ABT ... Advertisement Article continues below this ad The maker of infant formula, medical devices and drugs posted revenue of $10.36 billion in the period, which ...

Abbott Laboratories forecasts an impact of "a few hundred million dollars" this year from Trump administration tariffs, Chief ...

Q1 2025 Earnings Conference Call April 16, 2025 9:00 AM ETCompany ParticipantsMike Comilla - VP, IRRobert Ford - Chairman ...

Shares of ABT stock opened at $131.00 on Thursday. The company has a quick ratio of 1.14, a current ratio of 1.60 and a debt-to-equity ratio of 0.32. Abbott Laboratories has a 52 week low of $99. ...